Jordi Remon (J Remon)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Topics

Tyrosine Kinase

Liver Metastases

Clinical Practice

Small Cell Lung Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Pernelle Lavaud, Martina Bortolot, Lodovica Zullo, David O'Reilly, Jarushka Naidoo, Giannis Mountzios, Ida Chiara Guerrera, Lizza E L Hendriks, Jordi Remon
Early-Stage Non-Small Cell Lung Cancer: New Challenges with Immune Checkpoint Blockers and Targeted Therapies. Cancers 16 (16) (2024)
Stephanie P L Saw, Xiuning Le, Lizza E L Hendriks, Jordi Remon
New Treatment Options for Patients With Oncogene-Addicted Non-Small Cell Lung Cancer Focusing on EGFR -Mutant Tumors. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 44 (3) (2024)
Jordi Remon, Benjamin Besse, Santiago Ponce Aix, Ana Callejo, Kamal Al-Rabi, Reyes Bernabe, Laurent Greillier, Margarita Majem, Noemí Reguart, Isabelle Monnet, Sophie Cousin, Pilar Garrido Lopez, Gilles Robinet, Rosario Garcia Campelo, Anne Madroszyk, Julien Mazieres, Hubert Curcio, Bartosz Wasag, Yassin Pretzenbacher, Fanny Grillet, Anne-Marie C Dingemans, Rafal Dziadziuszko
Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR -Mutant Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Jordi Remon, Benjamin Besse, Santiago Ponce Aix, Ana Callejo, Kamal Al-Rabi, Reyes Bernabe, Laurent Greillier, Margarita Majem, Noemí Reguart, Isabelle Monnet, Sophie Cousin, Pilar Garrido Lopez, Gilles Robinet, Rosario Garcia Campelo, Anne Madroszyk, Julien Mazieres, Hubert Curcio, Bartosz Wasag, Yassin Pretzenbacher, Fanny Grillet, Anne-Marie C Dingemans, Rafal Dziadziuszko
Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR -Mutant Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jordi Remon, Benjamin Besse, Santiago Ponce Aix, Ana Callejo, Kamal Al-Rabi, Reyes Bernabe, Laurent Greillier, Margarita Majem, Noemí Reguart, Isabelle Monnet, Sophie Cousin, Pilar Garrido Lopez, Gilles Robinet, Rosario Garcia Campelo, Anne Madroszyk, Julien Mazieres, Hubert Curcio, Bartosz Wasag, Yassin Pretzenbacher, Fanny Grillet, Anne-Marie C Dingemans, Rafal Dziadziuszko
Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR -Mutant Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Pernelle Lavaud, Martina Bortolot, Lodovica Zullo, David O'Reilly, Jarushka Naidoo, Giannis Mountzios, Ida Chiara Guerrera, Lizza E L Hendriks, Jordi Remon
Early-Stage Non-Small Cell Lung Cancer: New Challenges with Immune Checkpoint Blockers and Targeted Therapies. Cancers 16 (16) (2024)
Jordi Remon, Benjamin Besse, Santiago Ponce Aix, Ana Callejo, Kamal Al-Rabi, Reyes Bernabe, Laurent Greillier, Margarita Majem, Noemí Reguart, Isabelle Monnet, Sophie Cousin, Pilar Garrido Lopez, Gilles Robinet, Rosario Garcia Campelo, Anne Madroszyk, Julien Mazieres, Hubert Curcio, Bartosz Wasag, Yassin Pretzenbacher, Fanny Grillet, Anne-Marie C Dingemans, Rafal Dziadziuszko
Overall Survival From the EORTC LCG-163 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR -Mutant Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Lizza E L Hendriks, Jordi Remon
Speeding up Antibody-Drug Conjugate Development in Pretreated EGFR -Mutant Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Dipesh Uprety, Jordi Remon, Solange Peters
First-Line Dual Immunotherapy, a Treatment Option in First-Line Metastatic Non-Small-Cell Lung Cancer: Are We Ready to Use It? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jordi Remon, R Bernabé, P Diz, E Felip, J L González-Larriba, M Lázaro, X Mielgo-Rubio, A Sánchez, I Sullivan, B Massutti
SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumours (2021). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 24 (4) (2022)
Jordi Remon, Lizza E L Hendriks, Martin Reck
The POSEIDON Trial: Will Secondary End Points Change Our Clinical Practice? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Martin Reck, Jordi Remon, Matthew D Hellmann
First-Line Immunotherapy for Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (6) (2022)
Jordi Remon, Francesco Facchinetti, Benjamin Besse
The efficacy of immune checkpoint inhibitors in thoracic malignancies. European respiratory review : an official journal of the European Respiratory Society 30 (162) (2021)
Jordi Remon, Lizza E L Hendriks, Benjamin Besse
Paving the Way for Long-Term Survival in Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (21) (2021)
Xabier Mielgo-Rubio, Margarita Martín, Jordi Remon, Oliver Higuera, Virginia Calvo, José Ramón Jarabo, Esther Conde, Javier Luna, Mariano Provencio Pulla, Javier De Castro Carpeño, Fernando López-Ríos, Florentino Hernando Trancho, Felipe Couñago
Targeted therapy moves to earlier stages of non-small-cell lung cancer: emerging evidence, controversies and future challenges. Future oncology (London, England) 17 (30) (2021)
Jordi Remon, Gilberto Lopes
Upfront osimertinib - winner takes it all? Nature reviews. Clinical oncology 17 (4) (2020)
Jordi Remon, F Tabbò, B Jimenez, A Collazo, J de Castro, S Novello
Sequential blinded treatment decisions in ALK-positive non-small cell lung cancers in the era of precision medicine. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (9) (2020)
Jose Carlos Benitez, Jordi Remon, Benjamin Besse
Current Panorama and Challenges for Neoadjuvant Cancer Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (19) (2020)
Xabier Mielgo-Rubio, Virginia Calvo, Javier Luna, Jordi Remon, Margarita Martín, Pedro Berraondo, José Ramón Jarabo, Oliver Higuera, Esther Conde, Javier De Castro Carpeño, Mariano Provencio, Florentino Hernando Trancho, Fernando López-Ríos, Felipe Couñago
Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers. Cancers 12 (11) (2020)
Sneha Gullapalli, Jordi Remon, Lizza E L Hendriks, Gilberto Lopes
Update on Targeted Therapies for Advanced Non-Small Cell Lung Cancer: Durvalumab in Context. OncoTargets and therapy 13 (2020)
Jordi Remon, R García-Campelo, E de Álava, R Vera, J L Rodríguez-Peralto, Á Rodríguez-Lescure, B Bellosillo, P Garrido, F Rojo, R Álvarez-Alegret
Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (6) (2019)